IN2014DN07984A - - Google Patents

Info

Publication number
IN2014DN07984A
IN2014DN07984A IN7984DEN2014A IN2014DN07984A IN 2014DN07984 A IN2014DN07984 A IN 2014DN07984A IN 7984DEN2014 A IN7984DEN2014 A IN 7984DEN2014A IN 2014DN07984 A IN2014DN07984 A IN 2014DN07984A
Authority
IN
India
Prior art keywords
chloroacetone
dimethylbenzene
bromo
preparation
discloses
Prior art date
Application number
Other languages
English (en)
Inventor
Doerwald Florencio Zaragoza
Anna Kulesza
Stephan Elzner
Robert Bujok
Zbigniew Wrobel
Krzysztof Wojciechowski
Original Assignee
Lonza Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=47557694&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=IN2014DN07984(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from PCT/EP2012/070875 external-priority patent/WO2012172121A1/en
Application filed by Lonza Ag filed Critical Lonza Ag
Publication of IN2014DN07984A publication Critical patent/IN2014DN07984A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • C07D233/58Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring nitrogen atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/41641,3-Diazoles
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D263/00Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/08Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D263/16Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Saccharide Compounds (AREA)
IN7984DEN2014 2012-06-28 2012-11-15 IN2014DN07984A (de)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
US201261665510P 2012-06-28 2012-06-28
EP12174102 2012-06-28
EP12188104 2012-10-11
PCT/EP2012/070875 WO2012172121A1 (en) 2012-06-28 2012-10-22 Method for the preparation of medetomidine with chloroacetone
EP12192625 2012-11-14
PCT/EP2012/072798 WO2013011157A1 (en) 2012-06-28 2012-11-15 Method for preparation of medetomidine with chloroacetone

Publications (1)

Publication Number Publication Date
IN2014DN07984A true IN2014DN07984A (de) 2015-05-01

Family

ID=47557694

Family Applications (1)

Application Number Title Priority Date Filing Date
IN7984DEN2014 IN2014DN07984A (de) 2012-06-28 2012-11-15

Country Status (21)

Country Link
US (2) US9156793B2 (de)
EP (1) EP2867211B1 (de)
JP (1) JP5777841B2 (de)
KR (1) KR101560116B1 (de)
CN (2) CN104245678B (de)
AU (1) AU2012285677B2 (de)
CA (1) CA2866437C (de)
CL (2) CL2014002907A1 (de)
CY (1) CY1117492T1 (de)
DK (1) DK2867211T3 (de)
EA (1) EA027921B1 (de)
ES (1) ES2565066T3 (de)
HK (2) HK1201530A1 (de)
HR (1) HRP20160216T1 (de)
HU (1) HUE027382T2 (de)
IN (1) IN2014DN07984A (de)
MY (1) MY165218A (de)
PL (1) PL2867211T3 (de)
SG (1) SG11201405609WA (de)
TW (2) TWI543970B (de)
WO (1) WO2013011157A1 (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SG11201405606RA (en) 2012-05-08 2014-11-27 Lonza Ag Method for preparation of medetomidine
KR101537204B1 (ko) 2012-05-08 2015-07-22 론자 아게 (론자 엘티디.) 2-(2,3-디메틸페닐)-1-프로파날의 제조 방법
PL2867195T3 (pl) 2012-06-28 2016-06-30 Lonza Ag Sposób wytwarzania 2-(2,3-dimetylofenylo)-1-propanalu przy pomocy chloroacetonu
CN104245678B (zh) * 2012-06-28 2016-02-24 隆萨有限公司 用氯丙酮制备美托咪定的方法
WO2017138224A1 (ja) * 2016-02-12 2017-08-17 ソニー株式会社 装置及び方法
CN106518812A (zh) * 2016-10-25 2017-03-22 湖南大学 一种美托咪定及其中间体的制备方法
CN113044857B (zh) * 2020-12-30 2023-05-23 重庆柒兴克米科技有限公司 高收率制取高纯氰化钠或氰化钾的生产工艺
CN114671811A (zh) * 2022-04-14 2022-06-28 南京正科医药股份有限公司 一种右美托咪定拆分副产物的外消旋化回收方法

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
USRE23400E (en) 1951-08-14 Electkic low and high-voltage fuses
BE790604A (fr) 1971-10-28 1973-04-26 Sandoz Sa Nouveaux aminoalcanols, leur preparation et leur application comme medicaments
JPS51100042A (en) 1975-02-26 1976-09-03 Kanebo Ltd 22 * 44 isobuchirufueniru * puropionsanno seizoho
JPS51100041A (en) 1975-02-26 1976-09-03 Kanebo Ltd 22 * 44 isobuchirufueniru * puropionsanno seizoho
GB2092569B (en) 1981-02-05 1984-09-19 Farmos Oy Substituted imidazole derivatives and their preparation and use
GB2101114B (en) 1981-07-10 1985-05-22 Farmos Group Ltd Substituted imidazole derivatives and their preparation and use
ATE78722T1 (de) 1984-02-24 1992-08-15 Sagami Chem Res Methode zum isomerisieren eines glycidats.
JPS62103037A (ja) * 1985-10-29 1987-05-13 Hamari Yakuhin Kogyo Kk 2−(4−イソブチルフエニル)−プロピオンアルデヒドの製造法
DE19714042A1 (de) 1997-04-05 1998-10-08 Henkel Kgaa Verfahren zur Herstellung aromatischer Aldehyde
SE513474C2 (sv) 1999-01-25 2000-09-18 Hans Elwing Instutionen Foer C Metod för att förhindra kräftdjurs, särskilt havstulpaners, etablering på fasta ytor med hjälp av en substans som stör nervsignaler, varvid substansen är medetomidin, dvs (+)-4-/1- (2,3-dimetylfenyl)-etyl/-IH-imidazol
EP1918282A1 (de) * 2006-11-06 2008-05-07 "Joint Stock Company Grindeks" Verfahren zur Herstellung von Medetomidine und ihre Salzen
GB2453982B (en) * 2007-10-24 2009-09-16 Norbrook Lab Ltd Chemical process for the preparation of Medetomidine
US7902247B2 (en) 2008-01-09 2011-03-08 Allergan, Inc. Substituted-aryl-2-phenylethyl-1H-imidazole compounds as subtype selective modulators of alpha 2B and/or alpha 2C adrenergic receptors
CN101921234B (zh) * 2009-06-12 2012-05-30 中国中化股份有限公司 一种制备美托咪啶的方法
WO2011070069A1 (en) 2009-12-09 2011-06-16 I-Tech Ab Process for preparation of medetomidine
KR101537204B1 (ko) 2012-05-08 2015-07-22 론자 아게 (론자 엘티디.) 2-(2,3-디메틸페닐)-1-프로파날의 제조 방법
SG11201405606RA (en) * 2012-05-08 2014-11-27 Lonza Ag Method for preparation of medetomidine
WO2012172119A2 (en) * 2012-05-08 2012-12-20 Lonza Ltd Method for the preparation of medetomidine
WO2012172120A2 (en) 2012-05-08 2012-12-20 Lonza Ltd 2-(2,3-dimethylphenyl)-1-propanal and its use as perfume
CN104245678B (zh) * 2012-06-28 2016-02-24 隆萨有限公司 用氯丙酮制备美托咪定的方法
WO2012172121A1 (en) * 2012-06-28 2012-12-20 Lonza Ltd Method for the preparation of medetomidine with chloroacetone
PL2867195T3 (pl) 2012-06-28 2016-06-30 Lonza Ag Sposób wytwarzania 2-(2,3-dimetylofenylo)-1-propanalu przy pomocy chloroacetonu
WO2012172122A2 (en) * 2012-06-28 2012-12-20 Lonza Ltd Method for the preparation of 2-(2,3-dimethylphenyl)-1-propanal

Also Published As

Publication number Publication date
CN105218453A (zh) 2016-01-06
US9434694B2 (en) 2016-09-06
US9156793B2 (en) 2015-10-13
CN104245678B (zh) 2016-02-24
TWI543970B (zh) 2016-08-01
CN105218453B (zh) 2017-04-12
CL2014002907A1 (es) 2015-01-16
US20150336909A1 (en) 2015-11-26
HK1213893A1 (zh) 2016-07-15
CN104245678A (zh) 2014-12-24
SG11201405609WA (en) 2015-02-27
CL2016001664A1 (es) 2017-01-27
AU2012285677A1 (en) 2014-09-25
MY165218A (en) 2018-03-09
WO2013011157A1 (en) 2013-01-24
EA027921B1 (ru) 2017-09-29
EP2867211B1 (de) 2015-12-30
CA2866437A1 (en) 2013-01-24
CA2866437C (en) 2018-01-02
EP2867211A1 (de) 2015-05-06
DK2867211T3 (en) 2016-02-29
KR20140129399A (ko) 2014-11-06
HRP20160216T1 (hr) 2016-03-25
CY1117492T1 (el) 2017-04-26
HK1201530A1 (zh) 2015-09-04
TW201630888A (zh) 2016-09-01
JP5777841B2 (ja) 2015-09-09
PL2867211T3 (pl) 2016-06-30
EA201400939A1 (ru) 2015-01-30
JP2015517474A (ja) 2015-06-22
ES2565066T3 (es) 2016-03-31
NZ700642A (en) 2016-04-29
HUE027382T2 (en) 2016-10-28
US20150099889A1 (en) 2015-04-09
TW201402553A (zh) 2014-01-16
KR101560116B1 (ko) 2015-10-13
TWI560182B (en) 2016-12-01
AU2012285677B2 (en) 2016-03-31

Similar Documents

Publication Publication Date Title
IN2014DN08121A (de)
IL249367A0 (en) Altered [4,2,1]triazole compounds
EP2936375A4 (de) Zeitgerechte, e-mail-eingebettete url-reputationsbestimmung
IN2014DN07984A (de)
MX2014002053A (es) Anticuerpos anti -mcsp y metodos de uso.
IN2014DN07983A (de)
JO3755B1 (ar) تركيبات تستوستيرون
WO2012172122A3 (en) Method for the preparation of 2-(2,3-dimethylphenyl)-1-propanal
IN2014CN04050A (de)
WO2014145897A3 (en) Immunotherapy system and method thereof
WO2012172119A3 (en) Method for the preparation of medetomidine
IN2014DN09798A (de)
WO2014091167A3 (fr) Composes cyclopropylboroniques, leur procede de preparation et leur utilisation
EP3184172B8 (de) Hydrosilylierungseisenkatalysator
IN2014CN00312A (de)
EA201400937A1 (ru) Способ получения 2-(2,3-диметилфенил)-1-пропаналя
MY165088A (en) Pharmaceutical compositions comprising alisporivir
EP3281180A4 (de) Erzeugung von optimierten geometrien
IN2012DN01971A (de)
GB201012359D0 (en) Invention 6.5.10
IL239340A0 (en) Sage fragrance
WO2014093305A3 (en) Micrornas and uses thereof
GB201015621D0 (en) Invention 30.08.10
UA111528C2 (uk) Спосіб одержання 2-(2,3-диметилфеніл)-1-пропаналю з використанням хлорацетону
MX2016016577A (es) Aleacion de fundicion de aluminio.